Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Song

Showing results (591-600 of 612) with videos related to

Pageof 62
Sort By:
Frontiers in Cellular and Infection Microbiology|February 18, 2021
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel CoronavirusYu-Zhong Zheng, Jiang-Tao Chen, Jian Li, et al.
JAMA Network Open|April 28, 2023
Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood CancerNoel-Marie Plonski, Cheng Chen, Qian Dong, et al.
Genome Medicine|April 7, 2021
Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime CohortNan Song, Chia-Wei Hsu, Haitao Pan, et al.
Journal of the National Cancer Institute|March 6, 2024
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancerNoel-Marie Plonski, Yue Pan, Cheng Chen, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutatedTanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
Epigenetics|February 3, 2022
Blood DNA methylation signatures are associated with social determinants of health among survivors of childhood cancerNan Song, Jin-Ah Sim, Qian Dong, et al.
BMC Medicine|December 29, 2022
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trialXinsheng Zhu, Liangdong Sun, Nan Song, et al.
Science (New York, N.Y.)|April 27, 2019
Long-term functional maintenance of primary human hepatocytes in vitroChengang Xiang, Yuanyuan Du, Gaofan Meng, et al.
Science Advances|May 6, 2021
PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stabilityShuai Ma, Cheng Cao, Shiyou Che, et al.
JAMA Network Open|July 2, 2024
Race and Ethnicity, Socioeconomic Factors, and Epigenetic Age Acceleration in Survivors of Childhood CancerCheng Chen, Noel-Marie Plonski, Qian Dong, et al.
Pageof 62

Showing results (591-600 of 612) with videos related to

Sort By:
Pageof 62
Frontiers in Cellular and Infection Microbiology|February 18, 2021
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel CoronavirusYu-Zhong Zheng, Jiang-Tao Chen, Jian Li, et al.
JAMA Network Open|April 28, 2023
Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood CancerNoel-Marie Plonski, Cheng Chen, Qian Dong, et al.
Genome Medicine|April 7, 2021
Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime CohortNan Song, Chia-Wei Hsu, Haitao Pan, et al.
Journal of the National Cancer Institute|March 6, 2024
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancerNoel-Marie Plonski, Yue Pan, Cheng Chen, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutatedTanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
Epigenetics|February 3, 2022
Blood DNA methylation signatures are associated with social determinants of health among survivors of childhood cancerNan Song, Jin-Ah Sim, Qian Dong, et al.
BMC Medicine|December 29, 2022
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trialXinsheng Zhu, Liangdong Sun, Nan Song, et al.
Science (New York, N.Y.)|April 27, 2019
Long-term functional maintenance of primary human hepatocytes in vitroChengang Xiang, Yuanyuan Du, Gaofan Meng, et al.
Science Advances|May 6, 2021
PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stabilityShuai Ma, Cheng Cao, Shiyou Che, et al.
JAMA Network Open|July 2, 2024
Race and Ethnicity, Socioeconomic Factors, and Epigenetic Age Acceleration in Survivors of Childhood CancerCheng Chen, Noel-Marie Plonski, Qian Dong, et al.
Pageof 62